Rallybio and Avenzo Merge to Advance Oncology Pipeline with $215M Financing
NEW HAVEN, Conn. & SAN DIEGO, Calif., June 2, 2026 Rallybio Corporation and Avenzo Therapeutics announced a definitive merger...
Private Placement
Advertisement
Glucotrack Raises $4M to Advance Implantable CGM System
Rutherford, New Jersey | December 30, 2025 — Glucotrack, Inc., a medical technology company focused on diabetes care innovation,...
Sharp Therapeutics Strengthens Path to Gaucher Trials
December 19, 2025 | Pittsburgh, Pennsylvania and Toronto, Ontario — Sharp Therapeutics Corp. has announced an updated non-brokered private...
Restart Life Secures Oversubscribed Financing to Advance Growth
Vancouver, British Columbia, December 18, 2025 — Restart Life Sciences Corp., a Canadian-based life sciences company, has successfully closed...
Restart Life Sciences Closes First Tranche to Advance Health Trials
VANCOUVER, British Columbia — December 5, 2025 — Restart Life Sciences Corp. announced the successful closing of the first...
Advertisements
Kazia Therapeutics Secures $50M Private Placement to Strengthen Pipeline Funding
Sydney, Australia, December 3, 2025 — Kazia Therapeutics has announced the pricing of a US $50 million private placement...
AB Science Secures €2.8 Million in Private Placement to Advance Clinical Pipeline
PARIS, October 17, 2025 AB Science S.A., a biopharmaceutical company focused on discovering, developing, and marketing protein kinase inhibitors,...
NeuroSense Therapeutics Announces $500,000 Private Placement at Premium to Market Price
NeuroSense Therapeutics Ltd. (NASDAQ: NRSN), a late-clinical stage biotechnology company developing therapies for neurodegenerative diseases, has entered into a...
Advertisement
